Electronic Interventions to Improve Quality for Inpatient Cirrhosis Care: A Prospective Evaluation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 39878433.
- Also identified by DOI 10.14309/ajg.0000000000003334 and PMC identifier 12304228.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Efforts to improve adherence to quality measures in cirrhosis care are encouraged by American Association for the Study of Liver Diseases (AASLD) to improve clinical outcomes. We prospectively evaluated 2 best practice advisory (BPA) interventions to alert clinicians caring for patients with cirrhosis and acute variceal hemorrhage or spontaneous bacterial peritonitis. Our BPAs increased utilization. Ceftriaxone use was associated with adverse outcomes such as more blood product and broad-spectrum antibiotic use. The albumin BPA was associated with reduced mortality. BPAs should be used with care and are best in settings with low baseline utilization of quality indicators.
Medical subject headings
- Liver Cirrhosis
- Quality Improvement
- Gastrointestinal Hemorrhage
- Peritonitis